UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4), p.807-818

2019

Volltextzugriff (PDF)

Affibody-DyLight conjugates for in vivo assessment of HER2 expression by near-infrared optical imaging

PloS one, 2012-07, Vol.7 (7), p.e41016-e41016

2012

Volltextzugriff (PDF)

Glioma-specific Domain IV EGFR cysteine mutations promote ligand-induced covalent receptor dimerization and display enhanced sensitivity to dacomitinib in vivo

Oncogene, 2015-03, Vol.34 (13), p.1658-1666

2015

Volltextzugriff (PDF)

Synuclein γ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption

Oncogene, 2015-04, Vol.34 (18), p.2398-2405

2015

Volltextzugriff (PDF)

A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma

Oncotarget, 2015-01, Vol.6 (1), p.185-195

2015

Volltextzugriff (PDF)

Inhibition of the UCI‐107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN‐238

Cancer, 2001-09, Vol.92 (5), p.1168-1176

2001

Volltextzugriff (PDF)

Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma

Gynecologic oncology, 2014-01, Vol.132 (1), p.166-175

2014

Volltextzugriff (PDF)

Metabolism and pharmacokinetics characterization of metarrestin in multiple species

Cancer chemotherapy and pharmacology, 2020-04, Vol.85 (4), p.805-816

2020

Volltextzugriff (PDF)

Pharmacologic characterization of fluzoparib, a novel poly(ADP‐ribose) polymerase inhibitor undergoing clinical trials

Cancer science, 2019-03, Vol.110 (3), p.1064-1075

2019

Volltextzugriff (PDF)

UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer

Journal of experimental & clinical cancer research, 2023-10, Vol.42 (1), p.270-270, Article 270

2023

Volltextzugriff (PDF)

CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer

British journal of cancer, 2022-06, Vol.126 (10), p.1470-1480

2022

Volltextzugriff (PDF)

PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage

Oncogene, 2010-07, Vol.29 (27), p.3881-3895

2010

Volltextzugriff (PDF)

Patient-derived xenograft models of breast cancer and their predictive power

Breast cancer research : BCR, 2015-02, Vol.17 (1), p.17-17, Article 17

2015

Volltextzugriff (PDF)

Improved Targeting and Tumor Retention of a Newly Synthesized Antineoplaston A10 Derivative by Intratumoral Administration: Molecular Docking, Technetium 99m Radiolabeling, and In Vivo Biodistribution Studies

Cancer biotherapy & radiopharmaceuticals, 2018-08, Vol.33 (6), p.221-232

2018

Volltextzugriff (PDF)

Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor

Investigational new drugs, 2014-04, Vol.32 (2), p.213-226

2014

Volltextzugriff (PDF)

The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis

Oncogene, 2015-02, Vol.34 (8), p.986-995

2015

Volltextzugriff (PDF)

Snail is critical for tumor growth and metastasis of ovarian carcinoma

International journal of cancer, 2010-05, Vol.126 (9), p.2102-2111

2010

Volltextzugriff (PDF)

Frizzled-5: a high affinity receptor for secreted frizzled-related protein-2 activation of nuclear factor of activated T-cells c3 signaling to promote angiogenesis

Angiogenesis (London), 2017-11, Vol.20 (4), p.615-628

2017

Volltextzugriff (PDF)

c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis

Molecular cancer, 2012-03, Vol.11 (1), p.15-15, Article 15

2012

Volltextzugriff (PDF)

TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer

Molecular cancer, 2013-12, Vol.12 (1), p.151-151, Article 151

2013

Volltextzugriff (PDF)

Mobilization of Hematopoietic Progenitor Cells by Yeast‐Derived β‐Glucan Requires Activation of Matrix Metalloproteinase‐9

Stem cells (Dayton, Ohio), 2008-05, Vol.26 (5), p.1231-1240

2008

Volltextzugriff (PDF)

Recombinant vesicular stomatitis virus targeted to Her2 neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors

Cancer gene therapy, 2009-01, Vol.16 (1), p.44-52

2009

Volltextzugriff (PDF)

Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis

Oncogene, 1998-10, Vol.17 (16), p.2019-2025

1998

Volltextzugriff (PDF)

Complete regression of MX‐1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone–releasing hormone, AN‐207

Cancer, 1999-06, Vol.85 (12), p.2608-2615

1999

Volltextzugriff (PDF)

Immunoconjugates of Geldanamycin and Anti-HER2 Monoclonal Antibodies: Antiproliferative Activity on Human Breast Carcinoma Cell Lines

JNCI : Journal of the National Cancer Institute, 2000-10, Vol.92 (19), p.1573-1581

2000

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

ThemaFemale

ThemaHumans

ThemaMice

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

11 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression

Affibody-DyLight conjugates for in vivo assessment of HER2 expression by near-infrared optical imaging

Glioma-specific Domain IV EGFR cysteine mutations promote ligand-induced covalent receptor dimerization and display enhanced sensitivity to dacomitinib in vivo

Synuclein γ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption

A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma

Inhibition of the UCI‐107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN‐238

Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma

Metabolism and pharmacokinetics characterization of metarrestin in multiple species

Pharmacologic characterization of fluzoparib, a novel poly(ADP‐ribose) polymerase inhibitor undergoing clinical trials

UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer

CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer

PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage

Patient-derived xenograft models of breast cancer and their predictive power

Improved Targeting and Tumor Retention of a Newly Synthesized Antineoplaston A10 Derivative by Intratumoral Administration: Molecular Docking, Technetium 99m Radiolabeling, and In Vivo Biodistribution Studies

Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor

The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis

Snail is critical for tumor growth and metastasis of ovarian carcinoma

Frizzled-5: a high affinity receptor for secreted frizzled-related protein-2 activation of nuclear factor of activated T-cells c3 signaling to promote angiogenesis

c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis

TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer

Mobilization of Hematopoietic Progenitor Cells by Yeast‐Derived β‐Glucan Requires Activation of Matrix Metalloproteinase‐9

Recombinant vesicular stomatitis virus targeted to Her2 neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors

Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis

Complete regression of MX‐1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone–releasing hormone, AN‐207

Immunoconjugates of Geldanamycin and Anti-HER2 Monoclonal Antibodies: Antiproliferative Activity on Human Breast Carcinoma Cell Lines

Aktive Filter

Suchergebnisse filtern